Recombinant Cetuximab anticorps
MALS verified
Reactivité: Humain
Hôte: Souris
Monoclonal
12B1E9
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits Cetuximab
- Cetuximab
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Cetuximab est non-conjugé
- Fonction
- Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)
- Attributs du produit
- Anti-idiotypic Antibodies
- Classe de qualité
- MALS verified
- Immunogène
- Anti-Cetuximab Antibody (12B1E9) (ABIN7482184) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293). The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab ADA.
- Clone
- 12B1E9
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
-
- Antigène
- Cetuximab
- Abstract
- Cetuximab Produits
- Classe de substances
- Antibody
- Sujet
- Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
-
Vous êtes ici:
